Table 3.
Demographic, anthropometric variables, nutritional intakes, biohumoral variables, and clinical-functional test of the admitted patients after randomization.
| Placebo | EAAs | p | |
|---|---|---|---|
| Age (yrs)† | 65.6 ± 9.50 | 67.9 ± 7.3 | 0.2 |
| M/F‡ | 10/20 | 14/16 | 0.3 |
| Body weight (kg)† | 73.0 ± 12.2 | 75.9 ± 15.9 | 0.3 |
| Body mass index (BMI) kg/m2 † | 27.5 ± 3.9 | 29.8 ± 4.2 | 0.07 |
| Time from index event (days)† | 16.0 ± 1.1 | 17.9 ± 1.2 | <0.05 |
| Length of stay (days)† | 15.2 ± 1.2 | 17 ± 0.8 | <0.08 |
| Daily nutritional intakes † | |||
| Energy (kcal) | 1980 ± 285 | 2210 ± 441 | 0.3 |
| kcal/kg | 27.1 ± 2.1 | 29.1 ± 4.33 | 0.5 |
| Carbohydrates (g/kg) | 3.7 ± 0.4 | 4.1 ± 0.8 | 0.8 |
| Proteins (g/kg) | 1.1 ± 0.4 | 0.9 ± 0.2 | 0.6 |
| Lipids (g/kg) | 0.95 ± 0.25 | 1.15 ± 0.40 | 0.8 |
| Blood biohumoral variables † | |||
| Glucose (mg/dL; n.v.∗ 70–110) | 82.2 ± 16.5 | 87.0 ± 15.5 | 0.6 |
| Urea (mg/dL; n.v.∗ 16–38) | 34.7 ± 10.9 | 35.7 ± 8.1 | 0.2 |
| Creatinine (mg/dL; n.v.∗ 0.6–1.1) | 0.73 ± 0.08 | 0.74 ± 0.09 | 0.2 |
| Erythrocyte sedimentation rate (mm/1 hr; n.v.∗: <12) | 45.3 ± 24.2 | 49.4 ± 28 | 0.4 |
| C-reactive protein (mg/dL; n.v.∗ <0.8) | 16.4 ± 11.7 | 20.5 ± 18.1 | 0.5 |
| Hemoglobin (g/dL; n.v.∗ >13 males and >12 females) | 10.4 ± 1.2 | 10.5 ± 0.96 | 0.1 |
| Ferritin (ng/mL; n.v.∗ 30–230 males and 10–120 females) | 206.7 ± 166 | 288 ± 212 | 0.3 |
| Transferrin (mg/dL; n.v.∗ 180–240) | 215 ± 34 | 191 ± 29 | <0.04 |
| Albumin (g/dL; n.v.∗ 3.5–5.5) | 3.62 ± 0 | 3.57 ± 0 | <0.07 |
| Total protein (g/dL; n.v.∗ 6–8) | 6.37 ± 0.51 | 6.1 ± 0.38 | <0.04 |
| α1-globulin (% total protein; n.v.∗ 2.9–4.9) | 6.7 ± 1.1 | 6.97 ± 1.38 | 0.1 |
| α2-globulin (% total protein; n.v.∗ 7.1–11.8) | 11.9 ± 2.5 | 11.1 ± 2.4 | 0.1 |
| Clinical-functional test # | |||
| Harris hip score | 39.78 ± 4.89 | 41.8 ± 1.15 | 0.9 |
Data are expressed as mean ± standard deviation. ∗Normal value.
Statistical analysis:
(a) †unpaired t-test;
(b) ‡Chi-square test;
(c) #Mann-Whitney test.